These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30176671)

  • 21. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL; Abud MB; Frantz KA; Rassi AR; Avila M
    Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema.
    Toda J; Fukushima H; Kato S
    Retina; 2007; 27(6):764-9. PubMed ID: 17621188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema.
    Ozkiris A; Evereklioglu C; Erkiliç K; Tamçelik N; Mirza E
    Eur J Ophthalmol; 2004; 14(6):543-9. PubMed ID: 15638105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Efficacy of Posterior Subtenon Triamcinolone Acetonide Injection in Treatment of Irvine-Gass Syndrome.
    Erden B; Çakır A; Aslan AC; Bölükbaşı S; Elçioğlu MN
    Ocul Immunol Inflamm; 2019; 27(8):1235-1241. PubMed ID: 31411519
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
    Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M
    Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.
    Yilmaz T; Weaver CD; Gallagher MJ; Cordero-Coma M; Cervantes-Castaneda RA; Klisovic D; Lavaque AJ; Larson RJ
    Ophthalmology; 2009 May; 116(5):902-11; quiz 912-3. PubMed ID: 19410949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema.
    Ozkurt YB; Akkaya S; Aksoy S; Evciman T; Haboğlu M
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):455-60. PubMed ID: 26154736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema.
    Dehghan MH; Ahmadieh H; Ramezani A; Entezari M; Anisian A
    Int Ophthalmol; 2008 Feb; 28(1):7-17. PubMed ID: 17589809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
    Kuley B; Storey PP; Wibbelsman TD; Pancholy M; Zhang QE; Sharpe J; Bello N; Obeid A; Regillo C; Kaiser RS; Chiang A; Fineman MS; Vander JF; Gupta OP; Spirn MJ; Dunn JP; Mehta S; Park CH; Maguire JI; Garg S
    Curr Eye Res; 2021 Jun; 46(6):824-830. PubMed ID: 33522311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
    Mahapatra SK; Kumari S
    Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.